Mutations in Extensively Drug‐ResistantMycobacterium tuberculosisThat Do Not Code for Known Drug‐Resistance Mechanisms
Author(s) -
Alifiya S. Motiwala,
Yang Dai,
Edward C. JonesLópez,
SooHee Hwang,
Jong Seok Lee,
Sang Nae Cho,
Laura E. Via,
Clifton E. Barry,
David Alland
Publication year - 2010
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/650999
Subject(s) - biology , mycobacterium tuberculosis , drug resistance , genetics , virology , extensively drug resistant tuberculosis , mutation , tuberculosis , resistance mutation , genome , multiple drug resistance , gene , medicine , polymerase chain reaction , reverse transcriptase , pathology
Highly lethal outbreaks of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are increasing. Whole-genome sequencing of KwaZulu-Natal MDR and XDR outbreak strains prevalent in human immunodeficiency virus (HIV)-infected patients by the Broad Institute identified 22 novel mutations which were unique to the XDR genome or shared only by the MDR and XDR genomes and not already known to be associated with drug resistance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom